资料显示，北京市春立正达医疗器械股份有限公司位于北京市通州区通州经济开发区南区鑫觅西二路10 号，成立日期1998年2月12日，上市日期2021年12月30日，公司主营业务涉及北京市春立正达医疗器械 股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中国公司。该公司主要产品 为关节假体产品及脊柱类植入产品。关节假体产品涵盖髋、膝、肩、肘四大人体关节。脊柱类植入产品 为脊柱内固定系统的全系列产品组合。该公司的产品出口至亚洲、南美洲、非洲、大洋洲及欧洲等多个 国家和地区。主营业务收入构成为：医疗器械产品99.89%，其他(补充)0.11%。 从春立医疗十大流通股东角度 数据显示，南方基金旗下1只基金位居春立医疗十大流通股东。南方医药保健灵活配置混合A （000452）二季度新进十大流通股东，持有股数160.3万股，占流通股的比例为0.42%。根据测算，今日 浮盈赚取约205.18万元。连续3天上涨期间浮盈赚取335.03万元。 来源：新浪基金∞工作室 10月20日，春立医疗涨5.15%，截至发稿，报26.13元/股，成交6718.33万元，换手率0.93%，总市值 100.23亿元。春立医疗股价已 ...

9月30日，春立医疗涨5.06%，截至发稿，报24.93元/股，成交4513.22万元，换手率0.65%，总市值95.62 亿元。 资料显示，北京市春立正达医疗器械股份有限公司位于北京市通州区通州经济开发区南区鑫觅西二路10 号，成立日期1998年2月12日，上市日期2021年12月30日，公司主营业务涉及北京市春立正达医疗器械 股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中国公司。该公司主要产品 为关节假体产品及脊柱类植入产品。关节假体产品涵盖髋、膝、肩、肘四大人体关节。脊柱类植入产品 为脊柱内固定系统的全系列产品组合。该公司的产品出口至亚洲、南美洲、非洲、大洋洲及欧洲等多个 国家和地区。主营业务收入构成为：医疗器械产品99.89%，其他(补充)0.11%。 从春立医疗十大流通股东角度 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，南方基金旗下1只基金位居春立医疗十大流通股东。南方医药保健灵活配置混合A （00045 ...

Core Viewpoint - Furu Pharmaceutical Co., Ltd. has seen a stock price increase of 5.38% to 66.38 CNY per share, with a total market capitalization of 17.589 billion CNY as of September 3 [1] Company Overview - Furu Pharmaceutical, established on December 26, 2001, and listed on January 20, 2010, is located in Chaoyang District, Beijing. The company specializes in the production and sales of drugs in the liver disease sector, as well as instrument research and sales, and medical services [1] - The revenue composition of Furu Pharmaceutical is as follows: 67.57% from equipment and technology, 27.47% from pharmaceuticals, 4.30% from medical services, and 0.65% from other sources [1] Shareholder Information - Southern Fund's Southern Medical Health Flexible Allocation Mixed A Fund (000452) is among the top ten circulating shareholders of Furu Pharmaceutical, having increased its holdings by 159,000 shares in the second quarter, totaling 3.8899 million shares, which represents 1.66% of the circulating shares [2] - The fund has achieved a year-to-date return of 55.82%, ranking 462 out of 8,180 in its category, and a one-year return of 55.38%, ranking 2,082 out of 7,967 [2] Fund Manager Performance - The fund manager of Southern Medical Health Flexible Allocation Mixed A Fund is Wang Zhengjiao, who has been in the position for 7 years and 41 days. The fund's total asset size is 2.417 billion CNY, with the best return during Wang's tenure being 74.43% and the worst being -53.83% [3] Fund Holdings - Southern Medical Health Flexible Allocation Mixed A Fund has Furu Pharmaceutical as its sixth-largest holding, with 5.22% of the fund's net value allocated to this stock [4]